Amazon.com said patients with Medicare Part D prescription plans now have access to certain GLP-1 weight-loss medications through Amazon Pharmacy

Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound and Foundayo will be available at a cost of $50 a month.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading